NIH funds data-driven Autism Data Science Initiative to study causes and outcomes of autism spectrum disorder 

The National Institutes of Health (NIH) has confirmed initiation of the Autism Data Science Initiative (ADSI), a $50 million program designed to integrate large-scale data and investigate factors contributing to autism spectrum disorder. The initiative will support 13 projects spanning genetics, exposomics, prevalence, and clinical outcomes. 

These multidisciplinary efforts will combine genetics, biology, and environmental science to study the complex contributors to autism. Alongside drawing on existing genomic, clinical, and behavioral datasets, the initiative will generate new data and validate findings through independent replication hubs to ensure transparency and reproducibility. 

According to the Centers for Disease Control and Prevention, autism prevalence in the US has increased from fewer than 1 in 2000 children in the 1970s to approximately 1 in 31 today. As the NIH notes: 

“Research supported by NIH and others has shown a strong genetic component to autism risk. However, nongenetic factors—such as environmental exposures and maternal health conditions—are less well understood.” 

A defining feature of ADSI is its focus on exposomics – the study of environmental, medical, and lifestyle influences alongside genetics and biology. Projects will assess exposures such as pesticides, air pollution, maternal nutrition, perinatal complications, psychosocial stress, and immune responses during pregnancy and early development. Advanced methodologies including machine learning, causal inference, exposome-wide analyses, and organoid models will be applied to explore gene–environment interactions and clarify contributors to prevalence trends. Independent replication hubs will test results across diverse populations. 

“Our Autism Data Science Initiative will unite powerful datasets in ways never before possible,” said NIH Director Jay Bhattacharya, MD, PhD “By bringing together genetics, biology, and environmental exposures, we are opening the door to breakthroughs that will deepen our understanding of autism and improve lives.” 

The 13 projects funded under ADSI cover a broad spectrum of research. For example, Wendy K Chung (Boston Children’s Hospital) will integrate genetic and environmental data in the SPARK autism cohort to predict susceptibility and heterogeneity, while Amy Louise Cochran (University of Wisconsin–Madison) will use causal inference methods to investigate autism’s heterogeneity and prevalence. 

The ADSI builds on NIH’s recently announced real-world data (RWD) platform for autism and chronic disease research. Nicole C Kleinstreuer, PhD, acting NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives, emphasized the significance of ASDI: 

“This initiative represents a turning point. Through NIH’s research we are building a foundation for discoveries that will change how autism is understood and addressed.” 

Each ADSI team will also work with autistic individuals, caregivers, and service providers to ensure the perspectives of the community inform study design and priorities. The initiative is managed by NIH’s Division of Program Coordination, Planning, and Strategic Initiatives, in collaboration with the National Institute of Environmental Health Sciences, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health, and the National Institute on Deafness and Other Communication Disorders.